Investor Presentation
136
Investor presentation First six months of 2022
Insulin market size and volume market share in
North America Operations
Total
Insulin market share and market size (DKK billion)
Long-
acting
37%
42%
Fast-
51%
76
acting
58%
Premix 8
26%
Human
15
Novo Nordisk
105
Competitors
NAO
Market
growth
A Market
share
Insulin volume: market share
60%
12%
204
3.1%
-0.2%
3.0%
-0.3%
40%
4.9%
-0.0%
20%
-6.7%
+0.9%
0%
May
2019
NN market share
0.9%
-1.6%
Note: Insulin market numbers do not reflect rebates. See slide 112.
Source: IQVIA, May 2022, LHS graph - Value, RHS Graph - Volume, MAT, all countries. Share of growth not depicted due to too high numbers; NN: Novo Nordisk
8%
38%
4%
-1%
0%
-3%
-4%
May
2022
-Market growth (right axis)
NN growth (right axis)View entire presentation